Increased serum low-density lipoprotein cholesterol in men treated short-term with the diuretic chlorthalidone.

doi:10.1016/0026-0495(80)90065-7

Paper

DOI: 10.1016/0026-0495(80)90065-7

Increased serum low-density lipoprotein cholesterol in men treated short-term with the diuretic chlorthalidone.

Published Mar 1, 1980 · Zeev Glück, Peter Weidmann, Rubino Mordasini

Metabolism: clinical and experimental

Q1 SJR score

Citations

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCT

Study Snapshot

Short-term diuretic therapy with chlorthalidone may increase serum LDL-C in young or middle-aged men with normal or high blood pressure.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Full text analysis coming soon...

References

DOI:

[The effect of diuretic therapy on serum lipoproteins: an undesirable effect?].

Diuretic therapy may increase serum beta or low-density-lipoprotein cholesterol, potentially affecting lipoprotein metabolism.

1979·24citations·Z. Glück et al.·Schweizerische medizinische Wochenschrift

Schweizerische medizinische Wochenschrift

DOI: 10.1016/0014-5793(78)80011-8

Quantitation of the major apoproteins of human high density lipoproteins by solid phase radioimmunoassay

This study developed a rapid and precise solid phase radioimmunoassay for quantifying apoprotein A-I and apoprotein A-II in human high density lipoproteins, aiding in understanding their structural and physiological functions.

1978·30citations·W. Riesen·FEBS Letters

FEBS Letters

DOI: 10.1056/NEJM197712222972502

Selective deficiency of hepatic triglyceride lipase in uremic patients.

Selective deficiency of hepatic triglyceride lipase in uremic patients may contribute to the accumulation of triglyceride-rich low-density lipoproteins in renal disease patients.

1977·181citations·R. Mordasini et al.·The New England journal of medicine

The New England journal of medicine

DOI: 10.1161/01.CIR.55.5.767

HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study

Lower HDL cholesterol levels are associated with an increased risk of coronary heart disease, regardless of LDL, total cholesterol, and triglyceride levels.

1977·1535citations·W. Castelli et al.·Circulation

Circulation

DOI: 10.1016/0002-9343(77)90316-3

Interrelations among blood pressure, blood volume, plasma renin activity and urinary catecholamines in benign essential hypertension.

Plasma renin activity, circulatory volume, and urinary catecholamines do not play major roles in maintaining benign essential hypertension, with low PRA reflecting diminished adrenergic activity and high PRA potentially due to hypovolemia from high blood pressure-induced sodium diuresis.

1977·88citations·P. Weidmann et al.·The American journal of medicine

The American journal of medicine

DOI: 10.1016/0002-9343(76)90156-X

Elevation of serum lipid levels during diuretic therapy of hypertension.

Diuretic therapy for hypertension can increase serum cholesterol and triglyceride levels, potentially contributing to the high rate of myocardial infarction during treatment.

1976·228citations·R. Ames et al.·The American journal of medicine

The American journal of medicine

Citations

DOI: 10.1097/MOL.0000000000000198

Unintended positive and negative effects of drugs on lipoproteins

Many medications can cause dyslipidaemia, while other drugs show positive effects on lipid metabolism, with the impact on atherosclerotic disease risk and progression unclear.

2015·5citations·T. Siahmansur et al.·Current Opinion in Lipidology

Current Opinion in Lipidology

DOI: 10.1111/J.0954-6820.1983.TB08587.X

Effect of furosemide on the lipid abnormalities in chronic renal failure.

Furosemide increases VLDL cholesterol and triglyceride levels in chronic renal failure patients, but these changes reverse when treatment is discontinued.

2009·5citations·A. Pasternack et al.·Acta medica Scandinavica

Acta medica Scandinavica

DOI: 10.1016/S0002-9343(96)00270-7

Metabolic manifestations of low-dose diuretics.

Low doses of hydrochlorothiazide effectively reduce blood pressure without significant metabolic side effects, making it a useful drug for treating hypertension both as monotherapy and in combination therapy.

1996·64citations·J. Neutel·The American journal of medicine

The American journal of medicine

DOI: 10.1007/BF00877100

Which diuretic to use?

The choice of diuretic depends on the patient's condition and complications, with thiazide group diuretics being the main cause of hypokalemia and metabolic upsets.

1994·0citations·C. Swanepoel·Cardiovascular Drugs and Therapy

Cardiovascular Drugs and Therapy

DOI: 10.1093/EURHEARTJ/13.SUPPL_G.61

Effect of diuretics on the plasma lipid profile.

Diuretics can affect lipid metabolism, potentially increasing the risk of heart attack and stroke, but premenopausal women may be protected from this side effect.

1992·45citations·P. Weidmann et al.·European heart journal

European heart journal